Massaro George's Form 4 filing
Charles River Laboratories International, Inc.CRL · filed May 16, 2024
- Accession no.
- 0001127602-24-015691
- Filed
- May 16, 2024
- Trade date
- May 15, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $78.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Massaro GeorgeCIK 0001221496 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | Common Stock | SSaleDisposed | −123 | $234.72F1 | −$28,870.56 | 6,064 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −113 | $235.61F2 | −$26,623.93 | 5,951 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −96 | $236.78F3 | −$22,730.88 | 5,855 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $234.27 to $235.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $235.35 to $236.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $236.36 to $237.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan.
Referenced by the price of 1 transaction in Table I.